Physician

Alexandra K. Wong, M.D.

According to 2025 Medicare claims, Alexandra Wong, M.D. (NPI: 1639673783) practices medical oncology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is CITY OF HOPE MEDICAL FOUNDATION (NPI: 1871886366; TIN: 274803222) and primary practice location at 91790-3912.

Wong's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 139 traditional Medicare patients, billed 30,694 HCPCS/CPT codes, and received $668,948 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 195 prescription claims across 63 beneficiaries totaling $522,276 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 31 records totaling $962. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,608 to $522,276. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$334K$669K2024 Medicare payment: $668,948 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202413930,694$668,948

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$261K$522K2019 Drug cost: $2,608 (USD; Tot_Drug_Cst)2020 Drug cost: $5,049 (USD; Tot_Drug_Cst)2021 Drug cost: $47,762 (USD; Tot_Drug_Cst)2022 Drug cost: $202,721 (USD; Tot_Drug_Cst)2023 Drug cost: $159,906 (USD; Tot_Drug_Cst)2024 Drug cost: $522,276 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R34$2,608
202032116$5,049
202151195$47,762
20224289$202,721
202347110$159,906
202463195$522,276

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less2963$119
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3437$111
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3135$79
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's4160$14
96372Injection of drug or substance under skin or into muscle2748$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban16690$13,255
PrednisonePrednisone11630$166
Amlodipine BesylateAmlodipine Besylate11795$131
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12143$68

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.31$962ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexandra K. Wong, M.D.?

Tedicare shows public-source Medicare data for Alexandra K. Wong, M.D. (NPI 1639673783), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandra K. Wong, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexandra K. Wong, M.D.?

Alexandra K. Wong, M.D. is linked to CITY OF HOPE MEDICAL FOUNDATION (billing NPI 1871886366) in the available physician profile data.

Does Alexandra K. Wong, M.D. have Open Payments data?

Alexandra K. Wong, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.